D.A., U. and N.I., K. 2024. Rosuvastatin and ezetimibe in the treatment of diabetic dyslipidemia in patients with type 2 diabetes mellitus. American Journal of Pediatric Medicine and Health Sciences (2993-2149). 2, 4 (Apr. 2024), 342–349.